SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-072407
Filing Date
2024-06-12
Accepted
2024-06-12 16:00:10
Documents
11
Period of Report
2024-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K glue-20240612.htm   iXBRL 8-K 58298
  Complete submission text file 0000950170-24-072407.txt   182380

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT glue-20240612.xsd EX-101.SCH 30849
14 EXTRACTED XBRL INSTANCE DOCUMENT glue-20240612_htm.xml XML 4894
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40522 | Film No.: 241038337
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)